Citadel Advisors’s Agile Therapeutics, Inc AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-19,247
| Closed | -$37.5K | – | 7108 |
|
|
2023
Q4 | $37.5K | Buy |
19,247
+6,422
| +50% | +$12.5K | ﹤0.01% | 5218 |
|
|
2023
Q3 | $30.9K | Buy |
+12,825
| New | +$30.9K | ﹤0.01% | 5217 |
|
|
2022
Q2 | – | Sell |
-13
| Closed | -$5K | – | 7307 |
|
|
2022
Q1 | $5K | Sell |
13
-72
| -85% | -$27.7K | ﹤0.01% | 6243 |
|
|
2021
Q4 | $84K | Buy |
85
+69
| +431% | +$68.2K | ﹤0.01% | 5994 |
|
|
2021
Q3 | $32K | Sell |
16
-49
| -75% | -$98K | ﹤0.01% | 6228 |
|
|
2021
Q2 | $174K | Sell |
65
-33
| -34% | -$88.3K | ﹤0.01% | 5664 |
|
|
2021
Q1 | $408K | Buy |
98
+49
| +100% | +$204K | ﹤0.01% | 4744 |
|
|
2020
Q4 | $280K | Buy |
49
+13
| +36% | +$74.3K | ﹤0.01% | 4283 |
|
|
2020
Q3 | $219K | Sell |
36
-12
| -25% | -$73K | ﹤0.01% | 4043 |
|
|
2020
Q2 | $268K | Buy |
48
+15
| +45% | +$83.8K | ﹤0.01% | 3885 |
|
|
2020
Q1 | $123K | Buy |
+33
| New | +$123K | ﹤0.01% | 4277 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 5282 |
|
|
2018
Q4 | – | Sell |
-32
| Closed | -$24K | – | 5078 |
|
|
2018
Q3 | $24K | Buy |
+32
| New | +$24K | ﹤0.01% | 4115 |
|
|
2016
Q1 | – | Sell |
-5
| Closed | -$106K | – | 4124 |
|
|
2015
Q4 | $106K | Buy |
+5
| New | +$106K | ﹤0.01% | 3236 |
|